GLP J-REIT
TSE:3281
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
117 100
142 900
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
GLP J-REIT
Balance Sheet
Balance Sheet Decomposition
GLP J-REIT
| Current Assets | 43.4B |
| Cash & Short-Term Investments | 25.3B |
| Receivables | 3.8B |
| Other Current Assets | 14.4B |
| Non-Current Assets | 846.4B |
| Long-Term Investments | 841B |
| PP&E | 120.7m |
| Intangibles | 2.9B |
| Other Non-Current Assets | 2.4B |
| Current Liabilities | 51.2B |
| Accounts Payable | 625.1m |
| Accrued Liabilities | 210.3m |
| Other Current Liabilities | 50.3B |
| Non-Current Liabilities | 372.8B |
| Long-Term Debt | 355.6B |
| Other Non-Current Liabilities | 17.1B |
Balance Sheet
GLP J-REIT
| Aug-2015 | Aug-2016 | Aug-2017 | Aug-2018 | Aug-2019 | Aug-2020 | Aug-2021 | Aug-2022 | Aug-2023 | Aug-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
5 582
|
5 191
|
8 389
|
7 618
|
12 318
|
9 466
|
14 636
|
27 259
|
23 060
|
25 254
|
|
| Cash Equivalents |
5 582
|
5 191
|
8 389
|
7 618
|
12 318
|
9 466
|
14 636
|
27 259
|
23 060
|
25 254
|
|
| Total Receivables |
256
|
818
|
1 613
|
4 757
|
2 081
|
2 348
|
1 805
|
1 753
|
3 481
|
3 751
|
|
| Accounts Receivables |
256
|
818
|
1 613
|
1 771
|
2 081
|
1 944
|
1 805
|
1 753
|
2 698
|
3 646
|
|
| Other Receivables |
0
|
0
|
0
|
2 986
|
0
|
404
|
0
|
0
|
782
|
106
|
|
| Other Current Assets |
5 913
|
5 618
|
7 057
|
8 405
|
9 720
|
10 397
|
11 988
|
12 184
|
13 429
|
14 399
|
|
| Total Current Assets |
11 751
|
11 627
|
17 059
|
20 779
|
24 119
|
22 211
|
28 428
|
41 196
|
39 970
|
43 404
|
|
| PP&E Net |
190
|
243
|
235
|
173
|
141
|
123
|
131
|
115
|
117
|
121
|
|
| PP&E Gross |
190
|
243
|
235
|
173
|
141
|
123
|
131
|
115
|
117
|
121
|
|
| Accumulated Depreciation |
64
|
94
|
126
|
159
|
188
|
213
|
240
|
262
|
283
|
298
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2 873
|
2 873
|
2 873
|
2 873
|
|
| Long-Term Investments |
339 918
|
374 682
|
423 795
|
506 080
|
584 091
|
615 428
|
751 144
|
737 741
|
850 376
|
840 956
|
|
| Other Long-Term Assets |
1 209
|
1 296
|
1 447
|
1 583
|
2 144
|
2 133
|
2 905
|
2 545
|
2 891
|
2 421
|
|
| Total Assets |
353 069
N/A
|
387 848
+10%
|
442 537
+14%
|
528 615
+19%
|
610 495
+15%
|
639 896
+5%
|
785 481
+23%
|
784 470
0%
|
896 226
+14%
|
889 775
-1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
228
|
248
|
299
|
342
|
378
|
397
|
406
|
536
|
605
|
625
|
|
| Accrued Liabilities |
305
|
735
|
1 184
|
61
|
1 330
|
124
|
201
|
786
|
190
|
210
|
|
| Short-Term Debt |
1 700
|
0
|
5 500
|
1 160
|
0
|
15 800
|
6 300
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
23 800
|
24 700
|
24 300
|
26 900
|
10 150
|
8 300
|
29 860
|
45 700
|
31 470
|
40 920
|
|
| Other Current Liabilities |
3 437
|
3 841
|
4 178
|
5 131
|
6 325
|
6 187
|
7 582
|
8 703
|
9 492
|
9 426
|
|
| Total Current Liabilities |
29 470
|
29 525
|
35 461
|
33 594
|
18 183
|
30 807
|
44 350
|
55 725
|
41 758
|
51 182
|
|
| Long-Term Debt |
151 080
|
164 130
|
182 640
|
210 120
|
262 450
|
259 800
|
310 360
|
300 820
|
365 090
|
355 640
|
|
| Other Liabilities |
7 527
|
7 699
|
8 516
|
10 969
|
11 747
|
12 645
|
15 228
|
15 323
|
17 063
|
17 132
|
|
| Total Liabilities |
188 077
N/A
|
201 354
+7%
|
226 617
+13%
|
254 683
+12%
|
292 380
+15%
|
303 252
+4%
|
369 937
+22%
|
371 868
+1%
|
423 911
+14%
|
423 954
+0%
|
|
| Equity | |||||||||||
| Common Stock |
160 342
|
181 242
|
209 527
|
265 985
|
308 499
|
326 945
|
403 779
|
396 146
|
458 276
|
451 817
|
|
| Retained Earnings |
4 650
|
5 252
|
6 393
|
7 947
|
9 615
|
9 698
|
11 764
|
16 457
|
14 039
|
14 004
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
164 992
N/A
|
186 494
+13%
|
215 920
+16%
|
273 932
+27%
|
318 114
+16%
|
336 644
+6%
|
415 543
+23%
|
412 602
-1%
|
472 315
+14%
|
465 822
-1%
|
|
| Total Liabilities & Equity |
353 069
N/A
|
387 848
+10%
|
442 537
+14%
|
528 615
+19%
|
610 495
+15%
|
639 896
+5%
|
785 481
+23%
|
784 470
0%
|
896 226
+14%
|
889 775
-1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
5
|
5
|
|
You don't have any saved screeners yet
